Your browser doesn't support javascript.
loading
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study.
Grosu, Horiana B; Kern, Ryan; Maldonado, Fabien; Casal, Roberto; Andersen, Clark R; Li, Liang; Eapen, Georgie; Ost, David; Jimenez, Carlos; Frangopoulos, Frangiskos; Sabath, Bruce; Vakil, Erik; Schwalk, Audra; Marcoux, Mathieu; Sagar, Ala Eddin; Nasim, Faria; Lin, Julie; Salahudin, Moiz; Arain, Hasan Muhammad; Noor, Laila; Montanez, Diana; Stewart, John; Mullon, John; Michael, Michalis; Porfyridis, Ilias.
Afiliação
  • Grosu HB; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kern R; Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Maldonado F; Division of Allergy, Pulmonary And Critical Care Medicine, Vanderbilt University, Nashville, Tennessee, USA.
  • Casal R; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Andersen CR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Li L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Eapen G; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ost D; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jimenez C; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Frangopoulos F; Pulmonary Department, Nicosia General Hospital, Nicosia, Cyprus.
  • Sabath B; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Vakil E; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Schwalk A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Marcoux M; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sagar AE; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nasim F; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lin J; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Salahudin M; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Arain HM; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Noor L; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Montanez D; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Stewart J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mullon J; Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Michael M; Cytopathology Department, Nicosia General Hospital, Nicosia, Cyprus.
  • Porfyridis I; Pulmonary Department, Nicosia General Hospital, Nicosia, Cyprus.
Respirology ; 27(5): 350-356, 2022 05.
Article em En | MEDLINE | ID: mdl-35178828
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Pleuroscopy with pleural biopsy has a high sensitivity for malignant pleural effusion (MPE). Because MPEs tend to recur, concurrent diagnosis and treatment of MPE during pleuroscopy is desired. However, proceeding directly to treatment at the time of pleuroscopy requires confidence in the on-site diagnosis. The study's primary objective was to create a predictive model to estimate the probability of MPE during pleuroscopy.

METHODS:

A prospective observational multicentre cohort study of consecutive patients undergoing pleuroscopy was conducted. We used a logistic regression model to evaluate the probability of MPE with relation to visual assessment, rapid on-site evaluation (ROSE) of touch preparation and presence of pleural nodules/masses on computed tomography (CT). To assess the model's prediction accuracy, a bootstrapped training/testing approach was utilized to estimate the cross-validated area under the receiver operating characteristic curve.

RESULTS:

Of the 201 patients included in the study, 103 had MPE. Logistic regression showed that higher level of malignancy on visual assessment is associated with higher odds of MPE (OR = 34.68, 95% CI = 9.17-131.14, p < 0.001). The logistic regression also showed that higher level of malignancy on ROSE of touch preparation is associated with higher odds of MPE (OR = 11.63, 95% CI = 3.85-35.16, p < 0.001). Presence of pleural nodules/masses on CT is associated with higher odds of MPE (OR = 6.61, 95% CI = 1.97-22.1, p = 0.002). A multivariable logistic regression model of final pathologic status with relation to visual assessment, ROSE of touch preparation and presence of pleural nodules/masses on CT had a cross-validated AUC of 0.94 (95% CI = 0.91-0.97).

CONCLUSION:

A prediction model using visual assessment, ROSE of touch preparation and CT scan findings demonstrated excellent predictive accuracy for MPE. Further validation studies are needed to confirm our findings.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Derrame Pleural / Derrame Pleural Maligno Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Derrame Pleural / Derrame Pleural Maligno Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article